Study tracking I2BS in Parkinson’s over time
Part of Brain & nervous system clinical trials.
This study follows people with Parkinson’s to see how “I2BS” changes over time using special brain scans and other tests. It may help researchers better understand Parkinson’s and improve how it’s measured in future trials.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 25 years or older and can sign consent after the study is explained to you
- You can come to the study site for scheduled visits and complete required tests (including scans and labs)
- You must be able to safely do the scan procedures, including having good hearing and sight for questionnaires
- If you could become pregnant: you must not be pregnant, not breastfeed, and use very reliable birth control
- If you’re on certain medicines (or have recent drug/alcohol misuse), you may not qualify—your current meds will be checked closely
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how well special brain scans (PET/SPECT) and spinal fluid tests can show changes in people with inherited (genetic) Parkinson’s. It may help researchers understand what’s happening in the brain and improve how these conditions are measured.
This study uses special scans to measure how serotonin is released in parts of the brain involved in movement in Parkinson’s disease. It may help researchers understand disease changes and the role of serotonin systems in movement problems.
This study uses special brain scans (PET/MR) to see inflammation in people with Parkinson’s disease or related conditions. It may help researchers better understand what drives symptoms and how inflammation changes in the brain.
This study uses a special PET scan to look at inflammation in the brain of people with Parkinson's disease or those at risk for it. The goal is to better understand the disease and possibly find new ways to track its progression.
This study uses a special PET scan to measure tau protein buildup in the brain of people with Parkinson's disease (including those with a LRRK2 gene mutation), Progressive Supranuclear Palsy, or Corticobasal Syndrome. It aims to better understand how tau relates to these conditions.
This study uses a new PET scan tracer called [11C]SY08 to take pictures of the brain in people with Parkinson's, multiple system atrophy, or dementia with Lewy bodies. It aims to see if this tracer can help better understand and tell apart these conditions.
Hear when a new Parkinson’s disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.